Literature DB >> 9268162

Type 1 HERV-K genome is spliced into subgenomic transcripts in the human breast tumor cell line T47D.

P R Etkind1, K Lumb, J Du, J Racevskis.   

Abstract

Two types of HERV-K genomes exist which differ in the absence (type 1) or the presence (type 2) of a sequence of 292 nucleotides between the putative pol and env genes. Previously published results from teratocarcinoma cell studies had firmly concluded that the type 1 HERV-K genome was defective in splicing and that only the nondeleted type 2 HERV-K genome containing the 292-nucleotide sequence was capable of being spliced. We now show that in the T47D human breast tumor cell line it is the type 1 HERV-K genome, and not the type 2, which is spliced to subgenomic transcripts.

Entities:  

Mesh:

Year:  1997        PMID: 9268162     DOI: 10.1006/viro.1997.8670

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer.

Authors:  Jing Zhao; Kiera Rycaj; Shanshan Geng; Ming Li; Joshua B Plummer; Bingnan Yin; Hong Liu; Xu Xu; Yinchun Zhang; Yanfang Yan; Sharon A Glynn; Tiffany H Dorsey; Stefan Ambs; Gary L Johanning; Lin Gu; Feng Wang-Johanning
Journal:  Genes Cancer       Date:  2011-09

2.  Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.

Authors:  Feng Wang-Johanning; Kiera Rycaj; Joshua B Plummer; Ming Li; Bingnan Yin; Katherine Frerich; Jeremy G Garza; Jianjun Shen; Kevin Lin; Peisha Yan; Sharon A Glynn; Tiffany H Dorsey; Kelly K Hunt; Stefan Ambs; Gary L Johanning
Journal:  J Natl Cancer Inst       Date:  2012-01-12       Impact factor: 13.506

3.  Mechanisms of HERV-K (HML-2) Transcription during Human Mammary Epithelial Cell Transformation.

Authors:  Meagan Montesion; Neeru Bhardwaj; Zachary H Williams; Charlotte Kuperwasser; John M Coffin
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

4.  Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.

Authors:  Feng Wang-Johanning; Ming Li; Francisco J Esteva; Kenneth R Hess; Bingnan Yin; Kiera Rycaj; Joshua B Plummer; Jeremy G Garza; Stefan Ambs; Gary L Johanning
Journal:  Int J Cancer       Date:  2013-09-13       Impact factor: 7.396

5.  Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.

Authors:  Feng Wang-Johanning; Laszlo Radvanyi; Kiera Rycaj; Joshua B Plummer; Peisha Yan; K Jagannadha Sastry; Chandrika J Piyathilake; Kelly K Hunt; Gary L Johanning
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

6.  Variant splicing and influence of ionizing radiation on human endogenous retrovirus K (HERV-K) transcripts in cancer cell lines.

Authors:  Lorenzo Agoni; Jack Lenz; Chandan Guha
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

7.  Differential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1.

Authors:  Neeru Bhardwaj; Meagan Montesion; Farrah Roy; John M Coffin
Journal:  Viruses       Date:  2015-03-04       Impact factor: 5.048

8.  Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.

Authors:  Aline Flockerzi; Alessia Ruggieri; Oliver Frank; Marlies Sauter; Esther Maldener; Bernd Kopper; Bernd Wullich; Wolfgang Seifarth; Nikolaus Müller-Lantzsch; Christine Leib-Mösch; Eckart Meese; Jens Mayer
Journal:  BMC Genomics       Date:  2008-07-29       Impact factor: 3.969

9.  Mouse mammary tumor virus (MMTV)-like DNA sequences in the breast tumors of father, mother, and daughter.

Authors:  Polly R Etkind; Alexandre Fr Stewart; Peter H Wiernik
Journal:  Infect Agent Cancer       Date:  2008-02-28       Impact factor: 2.965

Review 10.  Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?

Authors:  Ronan F Downey; Francis J Sullivan; Feng Wang-Johanning; Stefan Ambs; Francis J Giles; Sharon A Glynn
Journal:  Int J Cancer       Date:  2014-06-17       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.